News | August 21, 2024
Procter & Gamble Health reports Q4 sales at Rs. 277 Cr
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
India Business grew by 11.9% YoY to Rs. 1196.2 crore
European markets now contribute 51% of our business revenue up from 43% in Q4 FY24 and 34% in Q1 FY24
Q1FY25 Revenue from Operations grew by 15% to Rs. 177 crore
Vijaya Diagnostic Centre has reported total income of Rs. 159.78 crores during the quarter ended June 30, 2024
SMS Pharmaceuticals has reported total income of Rs. 165.81 crores during the quarter ended June 30, 2024
Divis Laboratories has reported total income of Rs. 2,197 crores during the period ended June 30, 2024
Strong topline growth driven by solid performance across key brands.
Reported profit after tax declined 19% year-on-year to Rs 76 crores
Solara Active Pharma Sciences has reported total income of Rs. 364.05 crores during the period ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated
